Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

NCT00106886 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT00106886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00106886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 1999
Completion date
October 31, 2005
Enrollment
5,000
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular disease, myocardial infarction, stroke